Nat'l Comparative Effectiveness Summit Features Cliff Goodman, PhD on Impact of CER on Innovation in New Technologies

The Third Nat'l Comparative Effectiveness Summit Features Cliff Goodman, PhD on Impact of CER on Innovation in New Technologies

Register for the National Comparative Effectiveness Summit by this Friday 9/9 for Early Bird Rate
Hybrid Conference and Internet Event
October 12 - 14, 2011
Onsite at the Mandarin Oriental, Washington, DC
Online In Your Own Office or Home live via the Internet with 24/7 Access for Six Months
www.ComparativeEffectivenessSummit.com

CONTACT
Phone: (800) 503-8960
Email: registration@hcconferences.com
Website: www.ComparativeEffectivenessSummit.com

EARLY BIRD REGISTRATION DISCOUNT
- SAVE $400 -

FEATURING ON IMPACT OF CER ON NEW TECHNOLOGIES

Cliff Goodman, PhD, Senior Vice President and Principal, The Lewin Group; Chair, Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), Centers for Medicare & Medicaid Services, Washington, DC

WASHINGTON DC USA -- AUGUST 30, 2011: The National Comparative Effectiveness Summit, www.ComparativeEffectivenessSummit.com, will take place October 12 - 14, 2011 at the Mandarin Oriental, Washington, DC.

COMPARATIVE EFFECTIVENESS SUMMIT ONLINE ARCHIVE LOG IN

Click here to log into Comparative Effectiveness video archive.

MEDIA PARTNERS

GRANTORS
DIAMOND

GOLD

BRONZE

CO-LOCATED WITH

FIRST NATIONAL BUNDLED PAYMENT SUMMIT

A Hybrid Conference and Internet Event
The Leading Forum on the Role of Healthcare Payment Reforms with Special Focus on Bundled Payment Approaches
Sponsored by the Integrated Healthcare Association
October 12 - 14, 2011
Mandarin Oriental
Washington, DC
www.BundledPaymentSummit.com

BROCHURE NOW AVAILABLE

Click here to view the Summit Brochure.

FEATURING PRECONFERENCE ON
Communicating Comparative Effectiveness Data to Physicians and Patients: Academic Detailing and Shared Decision Making

AND SPECIAL SESSIONS ON
The Role of the Patient-Centered Outcomes Research Institute (PCORI) The Role of AHRQ in Comparative Effectiveness Research The Role of NIH in Comparative Effectiveness Research How States are Already Using Comparative and Cost-Effective Research Comparative Effectiveness Research and Personalized Medicine How to Frame CER Research Priorities, Inclusion/Exclusion of Cost Issues, and Formatting of Products Methods and Data Infrastructure Needed for CER Practice-Based Evidence Study Design for Comparative Effectiveness Research The Role of Comparative Effectiveness Research in Health Plan Operations Systematic Reviews of Comparative Effectiveness: The Payor View How Real World Evidence can help Payers Supplement Randomized Trial Data to make Informed Formulary Decisions Heterogeneous Treatment Effects and the Implications of Average-Based Policies Asymmetries in Access to Data, Evidence Thresholds and the Ability to Convey Information The Impact of Comparative Effectiveness Research on Future Innovation The Impact of Comparative Effectiveness Research on Innovation in new Technologies The Impact of CER on Pharmaceutical Innovation, Value of Health and Longevity How to Reward Innovation and Value in Comparative Effectiveness Research The Role of Comparative Effectiveness Research in Value-Based Insurance Design How Comparative Effectiveness Research can be Used by ACOs The Role of Comparative Effectiveness Research in Provider Payment Reform The Implications of CER for Complementary and Alternative Medicine Comparative Effectiveness Research from the Patient Perspective Comparative Effectiveness Research and Shared Decision Making How Kaiser Uses Comparative Effectiveness Research in Patient Care

FREE SUBSCRIPTION TO MONTHLY
COMPARATIVE EFFECTIVENESS eNEWSLETTER

Click here to subscribe to a monthly Accountable Care Update eNewsletter, one of a family of free eNewsletters providing a complimentary video presentation and regularly updated news and key resources on major health care issues. To view and subscribe to other eNewsletters on patient safety, ACOs, Medicaid, pay for performance, and readmissions, go to www.HealthCareeNewsletters.com.

COMPARATIVE EFFECTIVENESS SUMMIT IS

THIRD NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT October 12 - 14, 2011
ONSITE Mandarin Oriental Washington, DC	OR	ONLINE In your own office or home live via the Internet with 24/7 access for six months

KEYNOTE SPEAKERS

Carolyn M. Clancy, MD
Director, Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services, Washington, DC

Francis S. Collins, MD, PhD
Director, National Institutes of Health, Former Director, National Human Genome Research Institute, Author, The Language of Life: DNA and the Revolution in Personalized Medicine (2010), Bethesda, MD

Joe V. Selby, MD, MPH
Executive Director, Patient-Centered Outcomes Research Institute, Former Director of the Research Division, Kaiser Permanente, Northern California, Washington, DC

SUMMIT CO CHAIRS

Robert W. Dubois, MD, PhD
Chief Science Officer, National Pharmaceutical Council, Reston, VA

John Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC

Paul Wallace, MD
Senior Vice President and Director of the Center for Comparative Effectiveness Research, The Lewin Group, Washington, DC

FEATURED FACULTY

Edward Abrahams, PhD President, Personalized Medicine Coalition, Former Executive Director, Pennsylvania Biotechnology Association, Washington, DC	Jerry Avorn, MD Professor of Medicine, Harvard Medical School, Chief, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Author, "Debate About Funding Comparative Effectiveness Research," New England Journal of Medicine, Boston, MA	Michael J. Barry, MD President, Foundation for Informed Medical Decision Making, Director of the Health Services Research Program and Chief, General Medicine Unit and Medical Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital, Professor of Medicine, Harvard Medical School, Boston, MA
Ian D. Coulter, PhD Samueli Institute Chair in Policy for Integrative Medicine and Senior Health Policy Analyst, The RAND Corporation, Professor, School of Dentistry, UCLA, Research Professor, Southern Calif. University of Health Sciences, Santa Monica, CA	John Doyle, PhD, MPH Vice President, Practice Leader, Consulting Solutions, Quintiles, New York, NY	A. Mark Fendrick, MD Co-Director, University of Michigan Center for Value-Based Insurance Design and Professor in the Departments of Internal Medicine and Health Management and Policy, University of Michigan, Ann Arbor, MI
Michael A. Fischer, MD, MS Assistant Professor of Medicine, Harvard Medical School, Director, National Resource Center for Academic Detailing, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA	Mark Gibson Deputy Director, Center for Evidence-Based Policy, Oregon Health and Science University, Program Officer, Milbank Memorial Fund, Former Chief of Staff, Oregon Senate President John Kitzhaber, Portland, OR	Robert M. Goldberg, PhD Co-Founder and Vice President, Center for Medicine in the Public Interest, New York, NY
Dana Goldman, PhD Director, Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, RAND Chair in Health Economics and Director of Health Economics, RAND, Los Angeles, CA	Cliff Goodman, PhD Senior Vice President and Principal, The Lewin Group, Chair, Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), Centers for Medicare & Medicaid Services, Washington, DC	Scott Gottlieb, MD Medical Internist, Stamford Hospital, Former Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration, Former Senior Adviser to the Administrator, CMS, Stamford, CT
Jessie C. Gruman, PhD Founder and President, Center for the Advancement of Health, Co-editor, Journal of Participatory Medicine, Washington, DC	Carol Havens, MD Director of Clinical Education, Kaiser Permanente Northern California, Sacramento, CA	Susan D. Horn, PhD Senior Scientist, Institute for Clinical Outcomes Research, Vice President of Research, International Severity Information Systems, Inc. (ISIS), Salt Lake City, UT
Jeffrey C. Lerner, PhD President and Chief Executive Officer, ECRI Institute, Plymouth Meeting, PA	Sharon Levine, MD Associate Executive Director, The Permanente Medical Group of Northern California, Member, Board of Governors, Patient-Centered Outcomes Research Institute (PCORI), Oakland, CA	Lorna A. Lynn, MD Director of Recertification, American Board of Internal Medicine, Philadelphia, PA
Lyn Paget Director of Policy and Outreach, Foundation for Informed Medical Decision Making, Boston, MA	Barry Patel, PharmD President and Co-Founder, Total Therapeutic Management, Kennesaw, GA	Doris Peter, PhD Manager, Consumer Reports Ratings Center and Principal Investigator, Consumer and Prescriber Education Grant Project, Consumer Reports, Yonkers, NY
Edmund Pezalla, MD, MPH National Medical Director for Pharmaceutical Policy and Strategy, Aetna, Former Chief Clinical Officer, Aetna Pharmacy Management, Hartford, CT	Hoangmai H. Pham, MD, MPH Director of ACO Programs, Center for Medicare and Medicaid Innovation, Center for Medicare and Medicaid Services, Former Co-director for Research, Center for Studying Health System Change, Baltimore, MD	Steven D. Pearson, MD, MSc, FRCP President, Institute for Clinical and Economic Review (ICER), Harvard Medical School, Former Special Advisor, Technology and Coverage Policy, Centers for Medicare and Medicaid Services, Boston, MA
Eugene C. Rich, MD, FACP Senior Fellow and Director, Center on Health Care Effectiveness, Mathematica Policy Research, Clinical Professor of Medicine, Creighton University School of Medicine, Washington, DC	Tom Snedden Director, Pharmaceutical Assistance, Contract for the Elderly (PACE), Commonwealth of Pennsylvania, Harrisburg, PA	Brian Sweet, RPh, MBA Executive Director, Development, AstraZeneca Pharmaceuticals, Former Chief Pharmacy Officer, WellPoint, Grand Island, NY

Sean Tunis, MD, MSc
Founder and Director, Center for Medical Technology Policy, Former Director, Office of Clinical Standards and Quality and Chief Medical Officer, Centers for Medicare and Medicaid Services, Baltimore, MD

John A. Vernon, PhD
Assistant Professor Health Policy and Management, Gillings School of Global Health, University of North Carolina at Chapel Hill, Raleigh, NC

ATTENDANCE OPTIONS

TRADITIONAL CONFERENCE ATTENDANCE

LIVE AND ARCHIVED INTERNET ATTENDANCE

Watch the conference in live streaming video over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

INTERNET INTERFACE SAMPLE
Click here for a sample stream

SUMMIT REGISTRATION

For Summit registration information, visit www.ComparativeEffectivenessSummit.com/registration.php, email registration@hcconferences.com, or call (800) 503-8960.

SUMMIT EXHIBIT & SPONSORSHIP INFORMATION

For sponsorship and exhibit information, visit www.ComparativeEffectivenessSummit.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at (206) 452-0609 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.

FIRST NATIONAL BUNDLED PAYMENT SUMMIT

THIRD NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT October 12 - 14, 2011

THIRD NATIONAL COMPARATIVE EFFECTIVENESS SUMMIT
October 12 - 14, 2011